NeuroTrigger Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$725K
- Investors
-
3
NeuroTrigger General Information
Description
Developer of a wearable muscle stimulator designed to improve or facilitate muscle performance by delivering electrical pulses to the muscles. The company's product specializes in rechargeable stimulators and a pre-gelled Y-shaped electrode that attaches to the stimulator by a magnetic flap and generates electrical pulses that are transmitted to the muscles through the electrode, causing the muscles to contract, enabling patients to self-administer muscle stimulation therapy at home or in the clinic.
Contact Information
Website
www.nt-med.comCorporate Office
- Hashizaf 4
- Raanana
- Israel
Corporate Office
- Hashizaf 4
- Raanana
- Israel
NeuroTrigger Timeline
NeuroTrigger Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 30-Dec-2025 | $725K | Completed | Generating Revenue | ||
| 7. Later Stage VC | 22-Apr-2025 | Completed | Generating Revenue | |||
| 6. Seed Round | 28-Jul-2023 | Completed | Clinical Trials - General | |||
| 5. Accelerator/Incubator | 04-May-2023 | Completed | Clinical Trials - General | |||
| 4. Accelerator/Incubator | 18-May-2022 | Completed | Clinical Trials - General | |||
| 3. Seed Round | 01-Jan-2022 | Completed | Clinical Trials - General | |||
| 2. Equity Crowdfunding | 01-Jan-2022 | Completed | Clinical Trials - General | |||
| 1. Grant | 26-Sep-2019 | $100K | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
NeuroTrigger Patents
NeuroTrigger Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-D1108371-S1 | Electrode device | Active | 16-May-2023 | ||
| EP-4713075-A1 | Wearable electrode device having magnetic connectors | Pending | 16-May-2023 | ||
| US-12157002-B1 | Wearable electrode device having magnetic connectors | Active | 16-May-2023 | ||
| US-20240382744-A1 | Wearable electrode device having magnetic connectors | Active | 16-May-2023 | ||
| US-20250090839-A1 | Wearable electrode device having magnetic connectors | Pending | 16-May-2023 | A61N1/0456 |
NeuroTrigger Signals
NeuroTrigger Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Medical Forge | Accelerator/Incubator | |||
| MassChallenge | Accelerator/Incubator | |||
| Merage Institute | Not-For-Profit Venture Capital |
NeuroTrigger FAQs
-
When was NeuroTrigger founded?
NeuroTrigger was founded in 2018.
-
Where is NeuroTrigger headquartered?
NeuroTrigger is headquartered in Raanana, Israel.
-
What is the size of NeuroTrigger?
NeuroTrigger has 6 total employees.
-
What industry is NeuroTrigger in?
NeuroTrigger’s primary industry is Therapeutic Devices.
-
Is NeuroTrigger a private or public company?
NeuroTrigger is a Private company.
-
What is NeuroTrigger’s current revenue?
The current revenue for NeuroTrigger is .
-
How much funding has NeuroTrigger raised over time?
NeuroTrigger has raised $2.95M.
-
Who are NeuroTrigger’s investors?
Medical Forge, MassChallenge, and Merage Institute have invested in NeuroTrigger.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process